Cystic echinococcosis (CE) is a zoonosis caused by metacestodes, the larval stage of
Echinococcus granulosus. Although the World Health Organization (WHO) has defined CE …

Simple Summary The purpose of this review is to provide an update on some of the most
promising non-oncology drugs that are already approved and that could be useful also in …

Repurposing of approved non-antitumor drugs represents a promising and affordable
strategy that may help to increase the repertoire of effective anticancer drugs. Benzimidazole …

Cystic echinococcosis still remains a serious health and economic problem worldwide. The
etiologic agent is Echinococcus granulosus sensu lato, giving origin to a fluid-filled cystic …

Cystic echinococcosis (CE) is a zoonotic parasitic disease with a cosmopolitan distribution,
and it is urgent to develop novel anti-helminthic agents. The intraperitoneal (ip) infection …

Objectives. Due to Albendazole's relatively low efficacy and bioavailability, Echinococcosis
has proven a challenge to manage successfully, with several studies investigating ways to …

Cystic echinococcosis is a zoonotic infection caused by the larval stage of Echinococcus
granulosus sensu lato. The disease is characterized by the long-term growth of cysts, most …

Cestodes are important endoparasitic organisms, some of which are responsible for serious
zoonotic diseases. The most severe diseases are inflicted by the larval stages …

Background: Cystic echinococcosis (CE) is a parasitic and zoonotic infection, recognized
globally as aneglected disease, with significant morbidity and mortality rates, especially in …

Alveolar echinococcosis is a life-threatening zoonotic disease caused by Echinococcus
multilocularis. The disease usually primarily involves the liver and shows tumor-like growth …